Company News
Haemonetics Shares Rise 16% on CSL Deal
Haemonetics stock surged 16.3% after announcing a non‑exclusive supply agreement with CSL Plasma Inc.
The deal lets CSL use Haemonetics’ NexSys PCS devices with Persona PLUS and disposables in the U.S
